TITLE

Experience with Simplified Scheme of Treatment of Hyperlipidaemia

AUTHOR(S)
Tabaqchali, Soad; Chait, Alan; Harrison, Rosamund; Lewis, Barry
PUB. DATE
August 1974
SOURCE
British Medical Journal;8/10/1974, Vol. 3 Issue 5927, p377
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64111383

 

Related Articles

  • Fibrates in hyperlipidaemia.  // Practice Nursing;Feb2010, Vol. 21 Issue 2, p90 

    The article provides an answer to a question on the evidence of using fibrates for hyperlipidaemia treatment.

  • Clinical: Hyperlipidaemia and hepatitis B.  // GP: General Practitioner;10/14/2005, p60 

    Presents a question and answer advisory related to the treatment of hyperlipidaemia and hepatitis B. Diagnosis of primary hyperlipidaemias using the Friedricksen classification; Cause of familial hyperchylomicronaemia; Loss of libido and erectile dysfunction from using a strong form of cannabis.

  • Rosuvastatin.  // Reactions Weekly;9/25/2010, Issue 1320, p38 

    The article describes the case of an older man who developed bilateral gynaecomastia during treatment with rosuvastatin for hyperlipidaemia and type 2 diabetes.

  • Atorvastatin/rosuvastatin.  // Reactions Weekly;11/3/2012, Issue 1426, p12 

    The article describes the case of a 51-year old man who developed hepatotoxicity following treatment with atorvastatin and rosuvastatin for hyperlipidaemia.

  • Atorvastatin/bezafibrate/fluvastatin.  // Reactions Weekly;5/14/2011, Issue 1351, p12 

    The article presents two cases of patients with hyperlipidaemia who developed myositis during treatment with atorvastatin or fluvastin, and bezafibrate.

  • Total cost minimization control scheme for biological wastewater treatment process and its evaluation based on the COST benchmark process. Yamanaka, O.; Obara, T.; Yamamoto, K. // Water Science & Technology;2006, Vol. 53 Issue 4/5, p203 

    This paper proposes a new cost minimisation control scheme for a predenitrification type of biological wastewater treatment process and evaluates the validity of the control scheme based on the benchmark process presented by Copp. The control scheme adopting a hierarchical control structure...

  • Clinical: Hyperlipidaemia.  // GP: General Practitioner;11/11/2005, p58 

    The article presents information on the treatment of hyperlipidaemia. It is informed that familial combined hyperlipidaemias are common, and are a genetically heterogeneous group of disorders presenting with isolated or mixed hyperlipidaemias and moderate family histories of CHD. Familial...

  • Simplified approach to double jumps for fluorescing dipole-dipole interacting atoms. Hannstein, V.; Hegerfeldt, G. C. // European Physical Journal D -- Atoms, Molecules, Clusters & Opti;May2006, Vol. 38 Issue 2, p415 

    A simplified scheme for the investigation of cooperative effects in the quantum jump statistics of small numbers of fluorescing atoms and ions in a trap is presented. It allows the analytic treatment of three dipole-dipole interacting four-level systems which model the relevant level scheme of...

  • Managing hyperlipidaemias. Buckley, Brendan M.; Bold, Alan M. // British Medical Journal (Clinical Research Edition);11/6/1982, Vol. 285 Issue 6351, p1293 

    Focuses on the management of patients with hyperlipidaemias. Criticisms on the drugs used for treatment of the disease; Characteristic of the disease; Requirements of assessing clinical symptoms and signs in monitoring the treatment of patients with the disease.

  • Olanzapine.  // Reactions Weekly;2/13/2010, Issue 1288, p29 

    The article describes the case of a 32-year-old man who acquired acute pancreatitis and hyperlipidaemia while undergoing treatment with olanzapine.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics